Back to search results

Lung Cancer Screening for Hispanic/Latinx Head and Neck Cancer Survivors

This study aims to improve awareness and use of lung cancer screening among Hispanic/Latinx individuals who have survived head and neck cancer. You may be able to join if you are 18 to 80 years old, identify as Hispanic/Latinx, and completed treatment for head and neck cancer at least 5 years ago with no signs of the cancer returning. The study involves providing tailored education about lung cancer screening and conducting interviews to understand what helps or hinders people from getting screened. Researchers will measure success by seeing if participants' understanding of lung cancer risks and screening recommendations improves over up to two years. The current recruitment status is unclear.

Study design
This is an interventional study with 44 planned participants. It focuses on providing education and understanding perceptions.
What's involved
You would have an annual 60-minute in-person educational visit, an annual 30-minute in-person or virtual interview, and a referral to a standard lung cancer screening program which includes a one-time 60-minute visit.
Compensation
Not stated in the trial record.
Follow-up
Participants' awareness and perception will be measured for up to two years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06124508

PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

Recruiting
NAAges 18–80InterventionalScreening
University of Miami
~44 participants
Updated 2026-04-28 on ClinicalTrials.gov
What's tested:Lung Cancer Screening EducationSemi-Structured InterviewStandard of Care Lung Cancer Screening Program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of participants' awareness of the risk of second primary lung cancer as measured by the University of Miami lung cancer screening program survey questionnaire.
Measured over Up to 2 Years
+3 more outcomes measured

Conditions

Head and Neck Cancer

Explore related trials

Malignant Head and Neck Neoplasm

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Coral Olazagasti, MD · PRINCIPAL_INVESTIGATOR · University of Miami

Who to contact

Coral Olazagasti, MD
[email protected]
305-243-4334
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants must be able to understand, and sign informed consent form.
Age ≥ 18 years.
Participants must self-identify as Hispanic/LatinX.
Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).
Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.

Exclusion

Individuals with pre-established diagnosis of lung cancer.
Participants with current diagnosis of any active malignancy.
Subjects that had undergone lung imaging within previous 3 years.
Pregnant or nursing mothers.
Individuals that received head and neck related treatment less than 5 years before screening.
Individuals with \< 20 pack year history of smoking.
Subjects with previous history of distant metastatic head and neck cancer.

What this trial measures

  • Proportion of participants' awareness of the risk of second primary lung cancer as measured by the University of Miami lung cancer screening program survey questionnaire.Up to 2 Years

    The proportion of participants' awareness of the risk of second primary lung cancer will be assessed via the University of Miami lung cancer screening program survey questionnaire. Awareness of the risk of second primary lung cancer will be reported as the proportion of participants that indicated 'Yes' and 'No' on the survey questionnaire.

  • Proportion of participants' awareness of lung cancer screening recommendations as measured by the University of Miami lung cancer screening program survey questionnaire.Up to 2 Years

    The proportion of participants' awareness of lung cancer screening recommendations will be assessed via the University of Miami lung cancer screening program survey questionnaire. Awareness of the lung cancer screening recommendations will be reported as the proportion of participants that indicated 'Yes' and 'No' on the survey questionnaire.

  • Proportion of participants' perception of the risk of second primary lung cancer as measured by the University of Miami lung cancer screening program survey questionnaire.Up to 2 Years

    The proportion of participants' perception of the risk of second primary lung cancer will be assessed via the University of Miami lung cancer screening program survey questionnaire. Perception of the risk of second primary lung cancer will be reported as the proportion of participants that indicated 'Yes' and 'No' on the survey questionnaire.

  • Proportion of participants' perception of lung cancer screening recommendations as measured by the University of Miami lung cancer screening program survey questionnaire.Up to 2 Years

    The proportion of participants' perception of lung cancer screening recommendations will be assessed via the University of Miami lung cancer screening program survey questionnaire. Perception of the lung cancer screening recommendations will be reported as the proportion of participants that indicated 'Yes' and 'No' on the survey questionnaire.